1/60
Looks like no tags are added yet.
Name  | Mastery  | Learn  | Test  | Matching  | Spaced  | 
|---|
No study sessions yet.
Limbic System
responsible for emotional expression, learning, and memory.
Hypothalamus
- Autonomic NS/ “Fight or Flight”
- Activates the sympathetic NS
- Causes the release of corticosteroids during anxiety.
Reticular formation
- connected to hypothalamus
- stimulation causes alertness/arousal; inhibition causes drowsiness/induction of sleep.
Cingulate gyrus
- Limbic system
- formation/processing emotions.
Locus Coeruleus
- Releases NE during periods of anxiety or stress to activate fight-or-flight
Thalamus
- regulate consciousness, sleep, and alertness.
Hippocampus
long-term storage of memory related to emotions.
Amygdala
Recognizes harmful stimuli and generates emotional responses (fear/anxiety)
Histamine receptors
- Some meds target histamine receptors for anxiety and insomnia
- can affect serotonin and other neurotransmitters
Which neurotransmitters is anxiety related to?
serotonin, norepinephrine, and GABA.
Types of anxiety disorders
1. generalized anxiety disorder
2. panic disorder
3. phobias
4. separation anxiety disorder
Related disorders to anxiey
OCD & PTSD
Generalized Anxiety Disorder (GAD)
- Persistent anxiety/fear related to daily life.
- Physical symptoms: palpitations, sweating, muscle tension due to limbic system activation of the sympathetic nervous system.
Panic Disorder
- Sudden panic attacks; recurrent and unexpected without triggers.
- Symptoms: palpitations, sweating, shortness of breath, hyperventilation, numbness, collapse.
Phobias
- Persistent, irrational fears.
- ie Social anxiety disorder
Separation Anixety Disorder
- Primarily affects children.
- Anxiety when separated from parents/caregivers
- crying and inconsolability.
obsessive-compulsive disorder (OCD)
Uncontrolled thoughts or repetitive behaviors.
Post-Traumatic Stress Disorder (PTSD)
Result of traumatic events.
Essentials for diagnosis
1. Persistent excessive anxiety or chronic fear with behavioral disturbances.
2. Somatic symptoms
3. Not due to physical disorders, schizophrenia, or drug abuse
Insomnia
Inability to fall or stay asleep; commonly associated with anxiety disorders.
Sleep disorders related to insomnia (3)
- Narcolepsy: Excessive daytime sleepiness.
- Obstructive Sleep Apnea (OSA): Airway obstruction during sleep.
- Restless Legs Syndrome (RLS): Urge to move legs.
Medications for insomnia/anxiety
- Benzodiazepines
- Nonbenzodiazepines
- Antidepressants
- Barbiturates
- First generation antihistamines
BAN FB
Sedative-hypnotics
- For insomnia/anxiety
- Calming effect at low doses; induce sleep at higher doses.
- Sublingual
Anxiolytics
Reduce anxiety by altering NE and serotonin levels.
Benzodiazepines
- Short-term therapy for anxiety and insomnia (due to risk for addiction/tolerance)
- Bind to GABA receptors, enhancing GABA's effects (don't mimic, so limited CNS depression)
Adverse effects of benzodiazepines
- Drowsiness/sedation/lethargy/confusion, headache, respiratory depression
- Use cautiously in older adults and pregnant women (↑ fall risk, cognitive impairment, teratogenic).
Chlordiazepoxide (librium)
- Benzodiazepine
- Side effect = lethargy
FDA approved benzodiazepines for anxiety
Alprazolam, Diazepam, Clonazepam, Lorazepam
CLAD
FDA approved benzodiazepines for insomnia
- Temazepam
- Triazolam
- Estazolam
TET
Flumazenil
- reversal agent for benzodiazepines
- competitively binds to the GABA receptor, blocking benzodiazepines
Nonbenzodiazepines
- Buspirone (FDA approved for anxiety)
- Z-drugs (FDA approved for insomnia).
Barbiturates
- Rarely used due to narrow therapeutic index/toxicity
- Bind to/mimic GABA (unlimited CNS depression potential)
- High addiction risk.
- No antidote; withdrawal managed with phenobarbital.
Types of barbiturates
Pentobarbital, Phenobarbital, Methohexital, Secobarbital.
First generation antihistamines
- Hydroxyzine (FDA approved for anxiety)
- Doxepin (FDA approved for anxiety)
- Diphenhydramine (FDA-approved for insomnia).
Types of antidepressants for anxiety and insomnia
1. Selective Serotonin Reuptake Inhibitors (SSRIs)
2. Atypical antidepressants- serotonin norepinephrine reuptake inhibitor (SNRIs)
3. Tricyclic Antidepressants (TCAs)
Selective Serotonin Reuptake Inhibitors (SSRIs)
- First-line for anxiety/depression.
- also treat eating disorders, panic disorder, OCD
- Block serotonin reuptake → increase serotonin availability/binding
- Fewer anticholinergic side effects.
SSRI Common side effects
Nausea, dry mouth, sleep disturbance, headache, GI upset, dizziness, fatigue, sexual dysfunction, weight gain
SSRI serious adverse affects
- Suicidal ideation
- Serotonin Syndrome
- Stevens-Johnson Syndrome (SJS)
Serotonin Sydrome
Hypothermia, tachycardia, hypertension, clonus, hyperreflexia, loss of consciousness, altered mental status.
Examples of SSRIs
- Fluoxetine, Citalopram, Escitalopram, Paroxetine, Sertraline, Fluvoxamine
- All FDA approved for anxiety
Serotonin norepinephrine reuptake inhibitor (SNRIs)
- inhibit reuptake of serotonin and NE
- More side effects than SSRIs.
- May require longer titrations
Examples of SNRIs
Duloxetine, Venlafaxine (FDA approved for anxiety), Desvenlafaxine
Venlafaxine
- SNRI
- Short half-life → fast effect but withdrawal risk if doses missed.
- Causes hypertension
Serotonin modulator
- SSRIs that partially agonize/antagonize 5-HT receptors.
- Used for treatment-resistant depression.
- Black Box Warning: Suicidality.
- SNRI/SSRI more effective
Trazodone
- serotonin modulator (old drug)
- off label for insomnia
- FDA approved for depression
- not typically used due to cardiac/anticholinergic effects
Nefazodone
- serotonin modulator (old drug)
- discontinued due to hepatotoxiicty
Examples of serotonin modulators- newer drugs
- vortioxetine
- vilazodone
- FDA-approved for depression only.
Tricyclic Antidepressants (TCAs)
- Affect serotonin and other neurotransmitters.
- Strong anticholinergic and cardiac toxicities.
Examples of TCAs
- Doxepin (FDA-approved for insomnia at low dose)
- Imipramine (off-label)
- Amitriptyline (off-label)
Z drugs
- non-benzodiazepine
- Bind to GABA receptor at benzodiazepine-binding site
- FDA-approved for insomnia: Zolpidem, Zaleplon, Eszopiclone
Non-benzodiazepine anxiolytics
Hydroxyzine, Buspirone, Meprobamate.
First-generation antipsychotics with anxiolytic effects
Prochlorperazine, Perphenazine, Quetiapine, Trifluoperazine.
Hydroxyzine (Atarax, Vistaril)
- First-gen antihistamine.
- FDA approved for anxiety
- Very sedating, highly anticholinergic; use with caution in pregnancy, avoid in lactation.
Buspirone (BuSpar)
- Partial agonist of serotonin receptors.
- now FDA approved for anxiety.
- Do not use with MAO inhibitors
Monoamine Oxidase Inhibitors (MAOIs)
- Nonselective inhibition of monoamine oxidase.
- Inhibit breakdown of tyramine (food-drug interaction risk)
- FDA Approved For: Depression only
- For patients unresponsive to SSRIs or TCAs.
MAOIs examples
phenelzine
tranylcypromine
selegiline transdermal
isocarboxazid
PITS
MAOI side effects
Drowsiness, orthostatic hypotension, vision changes, nausea, constipation, dry mouth, urinary retention, sexual dysfunction.
MAOI serious events
Suicidal ideation, hypertensive crisis, serotonin syndrome, circulatory collapse.
Antiseizure medications
Valproic acid.
Beta Blockers
- Propranolol- used for situational anxiety/migraines
- crosses BBB
Ramelteon
- melatonin receptor agonist; regulates wake-sleep cycles.
- FDA approved for insomnia